Conduent Applies GenAI to Revolutionize Detection of Reportable Events and Sets New Standard for FDA Compliance
Conduent Incorporated (Nasdaq: CNDT), a global technology-driven provider of business solutions and services, announced the launch of an advanced GenAI-powered platform designed to improve the detection of reportable events. This new solution establishes a modern benchmark for FDA compliance and enhances efficiency in the pharmaceutical and life sciences industries.
New GenAI-Powered Solution
Built on Microsoft Azure OpenAI technology, the platform automates the identification and classification of reportable events across all customer communication channels. It helps organizations streamline compliance workflows, reduce manual review time, and ensure faster, more accurate FDA reporting.
The solution leverages generative AI to seamlessly detect critical safety and regulatory events from diverse data sources, redefining how life sciences companies meet compliance expectations.
Contact Information
- Media: Sean Collins, Conduent, +1-310-497-9205, [email protected]
- Investor Relations: Joshua Overholt, Conduent, [email protected]
Summary
Conduent launches a GenAI platform powered by Azure OpenAI to transform FDA reporting processes, improving compliance accuracy and operational speed for life sciences organizations.